Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gauldie

Showing results (41-50 of 269) with videos related to

Pageof 27
Sort By:
The American Review of Respiratory Disease|March 1, 1985
Synthesis of alpha 1-protease inhibitor by resident and activated mouse alveolar macrophagesL R Lamontagne, A W Stadnyk, J Gauldie
Immunology|March 1, 1985
Activation of alveolar macrophages following infection with the parasitic nematode Nippostrongylus brasiliensisT G Egwang, A D Befus, J Gauldie
International Journal of Oncology|May 10, 2011
An adenoviral vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast-cancer modelC Addison, J Gauldie, W Muller, et al.
Regional Immunology|May 1, 1993
Cytokines in lung and airways fibrosisM Jordana, I Ohno, Z Xing, et al.
The Journal of Endocrinology|December 1, 1978
Effects of active immunization of female rabbits against testosteroneR W Armstrong, J Gauldie, E V YoungLai
Clinical Biochemistry|August 1, 1979
Motilin, human pancreatic polypeptide (HPP) and gastrin plasma concentrations in fasting subjectsN S Track, L M Watters, J Gauldie
The American Journal of Pathology|December 1, 1980
Immunohistochemical localization of alpha 1-antitrypsin in normal mouse liver and pancreasJ Gauldie, L Lamontagne, P Horsewood, et al.
Immunological Communications|January 1, 1975
Alteration of the HL-A antigenic site in situJ Gauldie, S C Bhandari, D P Singal
Current Opinion in Biotechnology|October 1, 1995
The use of adenoviral vectors for gene therapy and gene transfer in vivoJ L Bramson, F L Graham, J Gauldie
Journal of Immunological Methods|July 15, 1983
Lack of specificity of the C3-opsonized zymosan reagent for the assay of membrane complement receptorsT G Egwang, J Gauldie, A D Befus
Pageof 27

Showing results (41-50 of 269) with videos related to

Sort By:
Pageof 27
The American Review of Respiratory Disease|March 1, 1985
Synthesis of alpha 1-protease inhibitor by resident and activated mouse alveolar macrophagesL R Lamontagne, A W Stadnyk, J Gauldie
Immunology|March 1, 1985
Activation of alveolar macrophages following infection with the parasitic nematode Nippostrongylus brasiliensisT G Egwang, A D Befus, J Gauldie
International Journal of Oncology|May 10, 2011
An adenoviral vector expressing interleukin-4 modulates tumorigenicity and induces regression in a murine breast-cancer modelC Addison, J Gauldie, W Muller, et al.
Regional Immunology|May 1, 1993
Cytokines in lung and airways fibrosisM Jordana, I Ohno, Z Xing, et al.
The Journal of Endocrinology|December 1, 1978
Effects of active immunization of female rabbits against testosteroneR W Armstrong, J Gauldie, E V YoungLai
Clinical Biochemistry|August 1, 1979
Motilin, human pancreatic polypeptide (HPP) and gastrin plasma concentrations in fasting subjectsN S Track, L M Watters, J Gauldie
The American Journal of Pathology|December 1, 1980
Immunohistochemical localization of alpha 1-antitrypsin in normal mouse liver and pancreasJ Gauldie, L Lamontagne, P Horsewood, et al.
Immunological Communications|January 1, 1975
Alteration of the HL-A antigenic site in situJ Gauldie, S C Bhandari, D P Singal
Current Opinion in Biotechnology|October 1, 1995
The use of adenoviral vectors for gene therapy and gene transfer in vivoJ L Bramson, F L Graham, J Gauldie
Journal of Immunological Methods|July 15, 1983
Lack of specificity of the C3-opsonized zymosan reagent for the assay of membrane complement receptorsT G Egwang, J Gauldie, A D Befus
Pageof 27